81 related articles for article (PubMed ID: 3927035)
1. [Study on the levels of anti-A, anti-B isoagglutinin titer in various kinds of concentrates for hemophilia treatment--with special regard to the manufacturing process of factor VIII concentrate].
Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Sato R; Meguro T; Yamada K
Rinsho Ketsueki; 1985 Feb; 26(2):166-70. PubMed ID: 3927035
[No Abstract] [Full Text] [Related]
2. Hemolysis caused by factor VIII concentrates.
Orringer EP; Koury MJ; Blatt PM; Roberts HR
Arch Intern Med; 1976 Sep; 136(9):1018-20. PubMed ID: 962445
[TBL] [Abstract][Full Text] [Related]
3. High frequency of low plasma haptoglobin values found in hemophilia A patients on prophylactic treatment with factor VIII concentrates - a sign of hemolysis?
Egberg N; Blombäck M
Thromb Haemost; 1981 Aug; 46(2):554-7. PubMed ID: 6795743
[TBL] [Abstract][Full Text] [Related]
4. Levels of hepatitis B antigen and isoagglutinins in clinical concentrates of factor VIII and prothrombin complex.
Wickerhauser M
Dev Biol Stand; 1974; 27():172-7. PubMed ID: 4463121
[No Abstract] [Full Text] [Related]
5. Hemophiliac with hemolytic anemia resulting from factor VIII concentrate.
Soni NS; Patel AR; Vohra RM; Shah PC
Acta Haematol; 1977; 58(5):294-7. PubMed ID: 413305
[TBL] [Abstract][Full Text] [Related]
6. [Severe serogenic hemolytic anemia caused by anti-D fraction in factor VIII concentrate].
Schricker KT; Schrenk KH
Thromb Diath Haemorrh; 1972 Jul; 27(3):523-8. PubMed ID: 4197045
[No Abstract] [Full Text] [Related]
7. Hemolytic anemia due to anti-B in antihemophiliac factor concentrates.
Ashenhurst JB; Langehennig PL; Seeler RA; Telfer MC
J Pediatr; 1976 Feb; 88(2):257-8. PubMed ID: 1249687
[No Abstract] [Full Text] [Related]
8. [Case of hemolytic anemia following treatment with cryobulin].
Pluta A; Kniaź M; Kowalewski J
Wiad Lek; 1980 Apr; 33(7):555-7. PubMed ID: 6771920
[No Abstract] [Full Text] [Related]
9. Acquired hemolytic anemia and thrombocytopenia (Evans' syndrome) in hemophilia.
Harris PJ; Kessler CM; Lessin LS
N Engl J Med; 1983 Jul; 309(1):50. PubMed ID: 6406894
[No Abstract] [Full Text] [Related]
10. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
Klukowska A; Zieleniewska B
Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
Santagostino E; Gringeri A; Tagliavacca L; Mannucci PM
Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
[TBL] [Abstract][Full Text] [Related]
12. [Recent findings on hemophilia].
Abe T; Kinoshita T
Nihon Rinsho; 1981; 39(12):3647-56. PubMed ID: 6803031
[No Abstract] [Full Text] [Related]
13. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
Schimpf K; Schwarz P; Kunschak M
Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
[No Abstract] [Full Text] [Related]
14. [Treatment of haemophilia with factor VIII inhibitor by giving isoagglutinin-free factor VIII concentrate (author's transl)].
Bartholomé K; Geiger H; Schimpf K
Dtsch Med Wochenschr; 1976 Aug; 101(34):1252-4. PubMed ID: 947734
[TBL] [Abstract][Full Text] [Related]
15. Purity of concentrates for substitution therapy: acceptable and undesirable contaminants--Madrid 1978.
Scand J Haematol Suppl; 1980; 35():65-89. PubMed ID: 6770460
[No Abstract] [Full Text] [Related]
16. Hemophilia. Strategies for the treatment of inhibitor patients.
Ingerslev J
Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.
Ewenstein BM; Hoots WK; Lusher JM; DiMichele D; White GC; Adelman B; Nadeau K
Haematologica; 2000 Oct; 85(10 Suppl):35-9. PubMed ID: 11187868
[TBL] [Abstract][Full Text] [Related]
18. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic anemia due to anti-A in concentrated antihemophilic factor preparations.
Rosati LA; Barnes B; Oberman HA; Penner JA
Transfusion; 1970; 10(3):139-41. PubMed ID: 5422224
[No Abstract] [Full Text] [Related]
20. [Hemolytic anemia caused by infusion of factor VIII concentrates--a case report of hemophilia A with intracranial hemorrhage].
Fukazawa K; Okuyama T; Manabe H; Kanaya J
Rinsho Ketsueki; 1983 Jul; 24(7):892-6. PubMed ID: 6415317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
